{"annotatable":{"parts":["s1v1","s2v1","s3v1","s4v1","s5v1","s6v1","s7v1","s8v1","s9v1","s10v1","s11v1","s12v1","s13v1","s14v1","s15v1","s16v1","s17v1","s18v1","s19v1","s20v1"]},"anncomplete":true,"sources":[],"metas":{"m_82":{"value":"Some-concerns","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_83":{"value":"Some-concerns","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_84":{"value":"Some-concerns","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_85":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_86":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}},"m_35":{"value":"Some-concerns","confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1}}},"entities":[{"classId":"e_107","part":"s1v1","offsets":[{"start":1029,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s1v1","offsets":[{"start":1417,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s1v1","offsets":[{"start":1452,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_204","part":"s2v1","offsets":[{"start":4957,"text":"registered on clinicaltrials.gov (ID: NCT02112721)"}],"coordinates":[{"x":"187.60","y":"544.64"},{"x":"369.08","y":"550.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_216","part":"s2v1","offsets":[{"start":4990,"text":"(ID: NCT02112721)"}],"coordinates":[{"x":"296.57","y":"544.64"},{"x":"369.08","y":"550.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_210","part":"s2v1","offsets":[{"start":4995,"text":"NCT02112721"}],"coordinates":[{"x":"313.25","y":"544.64"},{"x":"365.97","y":"550.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_130","part":"s2v1","offsets":[{"start":5061,"text":"Participants were randomized to either the vitamin D group receiving an initial bolus dose of 100,000 IU (in 2 capsules) followed by 4,000 IU (in 4 capsules) of cholecalciferol daily, or the placebo group receiving an equivalent number of identical placebo capsules,"}],"coordinates":[{"x":"308.03","y":"566.64"},{"x":"441.50","y":"592.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s2v1","offsets":[{"start":5315,"text":"placebo"}],"coordinates":[{"x":"398.35","y":"586.64"},{"x":"425.22","y":"592.50"}],"confidence":{"state":"pre-added","who":["ml:regex","user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_117","part":"s2v1","offsets":[{"start":5646,"text":"Briefly, randomization was performed by an independent researcher not involved in the trial using a computerized random sequence generation program. Participants were randomized in blocks of four by sex and time of study entry (seasons) to ensure balance between sexes in each test group and to control for the effect of seasonal change."}],"coordinates":[{"x":"386.91","y":"616.64"},{"x":"442.32","y":"652.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_130","part":"s2v1","offsets":[{"start":5984,"text":"All capsules were identical and tasteless to maintain blinding, and all participants, investigators, and outcome assessors remained blinded until data analysis was complete."}],"coordinates":[{"x":"444.29","y":"646.64"},{"x":"252.56","y":"672.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_190","part":"s2v1","offsets":[{"start":6097,"text":"assessors remained blinded"}],"coordinates":[{"x":"437.32","y":"656.64"},{"x":"535.55","y":"662.50"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_181","part":"s3v1","offsets":[{"start":920,"text":"Blood Sample Analyses"}],"coordinates":[{"x":"155.64","y":"151.55"},{"x":"235.38","y":"157.41"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_216","part":"s3v1","offsets":[{"start":944,"text":"Fasting venous blood samples were drawn at baseline, and then after the 16-week inter-vention using standard phlebotomy techniques into serum separation vacutainers for measurement of serum inflammatory markers and 25(OH)D concentrations, respectively. All blood samples were analyzed under blinded conditions using standard quality control systems (all results within ± 2 SD). Serum 25(OH)D and hsCRP were measured by an accredited and quality-assured laboratory (Monash Health Pathology, Melbourne). Serum 25(OH)D was measured using direct competitive chemiluminescent immunoassays (CLIA) (DiaSorin Inc., MN, USA) with inter- and intra-assay coefficients of variation (CVs) of <10% and <4%, respectively. Plasma high sensitivity CRP (hsCRP) was measured by highly sensitive near-infrared particle immunoassay rate methodol-ogy on a Synchron LX system analyzer (Beckman Coulter Inc., Sydney, Australia) according to manufacturer’s instructions. Inter- and intra-assay CVs for hsCRP were <3% and <5%, respectively. Inflammatory markers were measured using a bead-based multi-analyte assay (LEGENDplex™ Human Inflammation panel, Cat. 740118; Biolegend, San Diego, CA). This panel was used to simultaneously quantify 13 pro- and anti- inflammatory cytokines/chemokines including TNF, monocyte chemoattractant protein-1 (MCP-1), interferon alpha (IFN-α) and gamma (IFN- γ), and IL-1β, IL-6, IL-8, IL-10, IL-12, IL-17A, IL-18, IL-23, and IL-33. Serum samples were diluted 2-fold based on preliminary testing and the kit-specified protocol was performed on 96-well v-bottom plates as follows. Sonicated pre-mixed beads, serum samples, cytokine standards, and detection antibodies were added to each well and then plates were incubated (in the dark) on a plate shaker at 600 rpm for 2 hours at room temperature (RT). Following incubation, streptavidin–phycoerythrin (SA-PE) solution was added to each well and further incubated on a plate shaker for 30 min at RT. The conjugated beads were then centrifuged (1000 g, 5 minutes, RT) and pelleted, and resuspended in wash buffer before being transferred to mini FACS tubes for data acquisition. Data acquisition was performed using the BD™ LSR II flow cytometer and FACS DIVA software set up as per manufacturer’s instructions (Becton Dickinson, San Diego, CA). Data were analyzed using the LEGENDplex™ Data Analysis Software (BioLegend, San Diego, CA) with standard curves generated from 0 to 50,000 pg/ml, and samples adjusted for the dilution factors. Inter- and intra-assay CVs for all analytes were <8% and <9%, respectively. Of the 13 cytokines, two were undetectable (IFN-γ and IL17A) in most of the samples and were therefore excluded from the analysis"}],"coordinates":[{"x":"246.48","y":"151.55"},{"x":"303.73","y":"407.40"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_186","part":"s3v1","offsets":[{"start":944,"text":"Fasting venous blood samples were drawn at baseline, and then after the 16-week inter-vention using standard phlebotomy techniques into serum separation vacutainers for measurement of serum inflammatory markers and 25(OH)D concentrations, respectively. All blood samples were analyzed under blinded conditions using standard quality control systems (all results within ± 2 SD). Serum 25(OH)D and hsCRP were measured by an accredited and quality-assured laboratory (Monash Health Pathology, Melbourne). Serum 25(OH)D was measured using direct competitive chemiluminescent immunoassays (CLIA) (DiaSorin Inc., MN, USA) with inter- and intra-assay coefficients of variation (CVs) of <10% and <4%, respectively. Plasma high sensitivity CRP (hsCRP) was measured by highly sensitive near-infrared particle immunoassay rate methodol-ogy on a Synchron LX system analyzer (Beckman Coulter Inc., Sydney, Australia) according to manufacturer’s instructions. Inter- and intra-assay CVs for hsCRP were <3% and <5%, respectively. Inflammatory markers were measured using a bead-based multi-analyte assay (LEGENDplex™ Human Inflammation panel, Cat. 740118; Biolegend, San Diego, CA). This panel was used to simultaneously quantify 13 pro- and anti- inflammatory cytokines/chemokines including TNF, monocyte chemoattractant protein-1 (MCP-1), interferon alpha (IFN-α) and gamma (IFN- γ), and IL-1β, IL-6, IL-8, IL-10, IL-12, IL-17A, IL-18, IL-23, and IL-33. Serum samples were diluted 2-fold based on preliminary testing and the kit-specified protocol was performed on 96-well v-bottom plates as follows. Sonicated pre-mixed beads, serum samples, cytokine standards, and detection antibodies were added to each well and then plates were incubated (in the dark) on a plate shaker at 600 rpm for 2 hours at room temperature (RT). Following incubation, streptavidin–phycoerythrin (SA-PE) solution was added to each well and further incubated on a plate shaker for 30 min at RT. The conjugated beads were then centrifuged (1000 g, 5 minutes, RT) and pelleted, and resuspended in wash buffer before being transferred to mini FACS tubes for data acquisition. Data acquisition was performed using the BD™ LSR II flow cytometer and FACS DIVA software set up as per manufacturer’s instructions (Becton Dickinson, San Diego, CA). Data were analyzed using the LEGENDplex™ Data Analysis Software (BioLegend, San Diego, CA) with standard curves generated from 0 to 50,000 pg/ml, and samples adjusted for the dilution factors. Inter- and intra-assay CVs for all analytes were <8% and <9%, respectively. Of the 13 cytokines, two were undetectable (IFN-γ and IL17A) in most of the samples and were therefore excluded from the a"}],"coordinates":[{"x":"246.48","y":"151.55"},{"x":"279.58","y":"407.40"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_166","part":"s3v1","offsets":[{"start":5194,"text":"The sample size calculation has been reported elsewhere27, and was based on the main study where insulin sensitivity was the primary outcome. Analyses were performed on a per-protocol basis using Stata V.12.1 (StatCorp LP, USA). Shapiro-Wilk tests and visual inspection of histograms and scatterplots were used to assess normality with the assistance of an experienced biostatistician. Baseline characteristics are presented as mean ± SD and frequencies (%), or median (interquartile range [IQR]) for skewed variables. Due to the skewed distributions of the inflammatory markers and NFκB activity, all results were analyzed using non-parametric tests. Spearman correlations and Mann-Whitney U-tests were used to examine associations at baseline between 25(OH)D concentrations and continuous and categorical variables, respectively. Within-group differences were assessed using Wilcoxon signed-rank tests. Differences between treatments groups were assessed using Mann-Whitney U-tests and chi-squared tests for continuous and categorical variables, respectively. Efficacy of the intervention on the outcomes (between-group differences) were analyzed using changes in outcome var-iables and quantile multiple regression (to examine difference in medians). In quantile multiple regression, we adjusted for those variables which were significantly associated with the outcome measure based on Spearman correlations, as well as other clinically relevant variables including baseline values, age, sex, and % body fat, and factors which may affect vitamin D status including season, sun exposure, and dietary vitamin D intake."}],"coordinates":[{"x":"255.42","y":"580.80"},{"x":"554.45","y":"726.65"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_150","part":"s3v1","offsets":[{"start":5335,"text":"Analyses were performed on a per-protocol basis using Stata V.12.1 (StatCorp LP, USA)."}],"coordinates":[{"x":"380.37","y":"590.80"},{"x":"294.96","y":"606.66"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_169","part":"s4v1","offsets":[{"start":948,"text":"By the end of the study, nine participants had dropped out and two were withdrawn (one due to protocol violation and one due to an adverse event of thrombophlebitis after an intravenous glucose tolerance test)."}],"coordinates":[{"x":"531.25","y":"580.80"},{"x":"488.83","y":"606.66"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_176","part":"s4v1","offsets":[{"start":973,"text":"nine participants had dropped out and two were withdrawn (one due to protocol violation and one due to an adverse event of thrombophlebitis after an intravenous glucose tolerance test)"}],"coordinates":[{"x":"216.49","y":"590.80"},{"x":"486.73","y":"606.66"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_150","part":"s4v1","offsets":[{"start":1158,"text":"The remaining 54 participants (vitamin D group = 28 and placebo group = 26)"}],"coordinates":[{"x":"490.88","y":"600.80"},{"x":"369.52","y":"616.66"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s4v1","offsets":[{"start":1217,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_156","part":"s4v1","offsets":[{"start":2509,"text":"Figure 1"}],"coordinates":[{"x":"155.64","y":"393.02"},{"x":"186.41","y":"398.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s4v1","offsets":[{"start":2509,"text":"Figure 1.  Participant Flowchart: Numbers of participants who were recruited, randomized, dropped out, and analyzed during the trial."}],"coordinates":[{"x":"155.64","y":"393.02"},{"x":"245.23","y":"408.88"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":882,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":1361,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":1662,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":1966,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":3768,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":3887,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":4039,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_121","part":"s5v1","offsets":[{"start":4087,"text":"Characteristics Vitamin D group (n = 28) Placebo group (n = 26) pMale, n (%) 17 (60.7) 18 (69.2) 0.5Age (years) 30.5 (25–35) 29.5 (25–41) 0.9Ethnicitya, n  Caucasian 9 5 0.2  South and Central Asian 8 9  South-East and North-East Asian 4 9  Otherb 5 2Sun exposure (index score)c 4.2 (1.6–6.3) 5.1 (2.0–6.9) 0.5Physical activity (IPAQ-METS score)c 1751 (920–3510) 2912 (1485–5544) 0.2Dietary vitamin D intake (IU)c 91.1 (54.6–130.9) 73.1 (61.0–110.8) 0.3Season of blood collection, n (%)          Winter 5 (17.8) 8 (30.7) 0.3          Spring 11 (39.3) 4 (15.4)          Summer 8 (28.6) 10 (38.5)          Autumn 4 (14.3) 4 (15.4)"}],"coordinates":[{"x":"158.76","y":"49.69"},{"x":"404.58","y":"228.64"}],"confidence":{"state":"pre-added","who":["user:katia-giacomino"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s5v1","offsets":[{"start":4131,"text":"Placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":660,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":1040,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":1357,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":1534,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":1966,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":2901,"text":"Placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":5801,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":5892,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s6v1","offsets":[{"start":5989,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s7v1","offsets":[{"start":1687,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s7v1","offsets":[{"start":1892,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s7v1","offsets":[{"start":3007,"text":"Placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s7v1","offsets":[{"start":3056,"text":"Placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s8v1","offsets":[{"start":2923,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s9v1","offsets":[{"start":3556,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s9v1","offsets":[{"start":3943,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s10v1","offsets":[{"start":1550,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s10v1","offsets":[{"start":3683,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s10v1","offsets":[{"start":4707,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s10v1","offsets":[{"start":5701,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s10v1","offsets":[{"start":7669,"text":"placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s11v1","offsets":[{"start":435,"text":"Placebo"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s13v1","offsets":[{"start":256,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s13v1","offsets":[{"start":538,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s13v1","offsets":[{"start":920,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s13v1","offsets":[{"start":949,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s14v1","offsets":[{"start":335,"text":"f"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s14v1","offsets":[{"start":393,"text":"f"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s14v1","offsets":[{"start":929,"text":"f"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s14v1","offsets":[{"start":998,"text":"f"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":334,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":388,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":906,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":960,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":1845,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":1862,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":2322,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s15v1","offsets":[{"start":2339,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":292,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":536,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":764,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":1004,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":1240,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":1792,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s17v1","offsets":[{"start":2365,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s18v1","offsets":[{"start":110,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":178,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":277,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":368,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":400,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":531,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":836,"text":"f"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":947,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":1060,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":1133,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":1278,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":1291,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":1330,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s19v1","offsets":[{"start":1340,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s20v1","offsets":[{"start":448,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}},{"classId":"e_160","part":"s20v1","offsets":[{"start":1462,"text":"F"}],"coordinates":[],"confidence":{"state":"pre-added","who":["ml:regex"],"prob":0.5},"fields":{},"normalizations":{}}],"relations":[]}